This study suggests a promising KDM5B‐targeted therapy for HCC patients and also proposes that a KDM5B/miR‐448/YTHDF3/ITGA6 axis is involved in the occurrence and development of this cancer, which could constitute an important tumour‐related molecular mechanism. The gene discussed is YTHDF3; the disease is cancer.